InMode Strengthens Leadership with New Chairman and CFO Appointments

InMode Ltd., a prominent player in the innovative medical technology sector, has taken a significant step forward in its leadership by appointing Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer (CFO). These appointments underscore the company’s commitment to robust governance and strategic long-term growth.

The announcement, made on May 20, 2026, follows the recent retirement of Dr. Michael Anghel, the former Chairman, who served the company with dedication over the years. Dr. Nass brings a wealth of experience in corporate law, accounting, and audit oversight, making him a valuable asset as the company navigates complex regulatory landscapes and seeks to enhance shareholder value. Chief Executive Officer Moshe Mizrahy expressed confidence in Dr. Nass’s capabilities, stating, "The deep expertise in corporate governance and financial oversight will be invaluable as we continue to execute our strategic priorities."

In a parallel move, Moshik Itzkovich has been appointed as the new CFO, succeeding Yair Malca, who has also stepped down. Moshik has an impressive track record at InMode, having played a key role as Senior Vice President of Finance. His transition to CFO is expected to provide the company with continuity and a strategic approach to financial management. Mizrahy commented, "Moshik brings continuity, financial expertise, and strategic insight to this role. We are confident he is well-positioned to build on our strong financial foundation."

Both appointments come at a time when InMode is poised to leverage its innovative radiofrequency technologies across various medical disciplines, including plastic surgery, gynecology, and dermatology. As InMode continues to develop and market its cutting-edge devices, the new leadership team aims to facilitate the company’s growth and drive long-term success.

Dr. Nass expressed gratitude to his predecessor, Dr. Anghel, for his dedicated service, emphasizing the importance of building upon the strong foundation established by previous leadership. He noted, "I look forward to working alongside the Board and management to support our strategic direction and uphold the highest standards of corporate governance."

InMode is known for its commitment to innovation, striving to enable new surgical procedures while improving existing treatment options through its medically accepted minimally invasive RF technologies. As the company continues to expand its product line, the appointments of Dr. Nass and Moshik Itzkovich highlight InMode’s strategic focus on leadership and governance.

InMode’s recent leadership changes point to a future in which the company is set to enhance its operational and financial strategies to enter new markets and drive innovation. The firm is recognized for its innovative approach and ability to adapt to the evolving medical technology landscape, which will be crucial as they work to maximize shareholder value and cater to a growing patient base worldwide.

In summary, InMode's decision to appoint Dr. Shlomo Nass and Moshik Itzkovich reflects its ambition to solidify its leadership in the medical technology industry, ensuring that they remain at the forefront of innovation while providing optimal value to shareholders and patients alike.